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Overlap syndrome is defined as entities satisfying the
classification criteria of at least two connective tissue diseases
(CTDs) occurring at the same or at different times in the
same patient. CTDs include systemic lupus erythematosus,
rheumatoid arthritis (RA), scleroderma (SSc), polymyositis/
dermatomyositis and Sjo¨gren syndrome.1 The most common
combinations are scleroderma with systemic lupus
erythematosus, Sjogren’s syndrome, rheumatoid arthritis
and dermatomyositis.2 Here, we discussed about a case ofhis is an open access article under the CC BY-NC-ND license
16/j.jtumed.2015.10.004
M.S. Jangala et al.78overlapping features of rheumatoid arthritis and
scleroderma along with interstitial lung disease and
pulmonary artery hypertension.Figure 2: Photograph of hands showing stellate heeled scars on
fingers and ankle.Case report
A 55-yr-old agriculture labourer from the rural area of the
Kadapa district of Andhra Pradesh was admitted to RIMS
Medical College Hospital with the complaints of fever,
cough and breathlessness for two weeks before admission as
well as joint pains and stiffness of fingers from the previous 6
months. She had been diagnosed with scleroderma (lcSSc)
for 2 yrs and had inconsistently been on medication. On
appearance, she had a mild pallor, typical face (Figure 1),
sclerodactyly (Figure 2), calcinosis cutis was present on the
dorsum of the right foot (Figure 3) and wasting of the
distal phalanges of the hand. Loss of joint range of
motion, pain and stiffness of the metacarpophalangeal
joints of her feet, as well as small joints (proximal
interphalangeal and metacarpophalangeal) of both hands
were effected.
On examination, her pulse rate was 82 beats/min, Blood
pressure 150/90 mmHg and S1 and S2 were positive. Her
respiratory rate was 20 cycles/min. Her oxygen saturation
was SpO2 90, and she had basal lung crepitations. On
abdominal examination, she had mild hepatomegaly. Her
urine output was normal. On cutaneous examination, skin
thickening and stellate healed scars on the fingers and ankle
were present, as well as stiffness, pain on motion and
deformity changes of her hands.Figure 3: Photographof the patient showing calcinosis cutis on legs.Patient’s laboratory and diagnostic data
Her reports showed nonreactive HIV, and the HBsAg was
negative. A 2D-ECHO cardiogram report showed pulmo-
nary artery hypertension with a mean pulmonary artery
pressure of 30 mmHg. A chest X-ray showed a linear and
reticular pattern, superimposed upon ground-glass attenua-
tion in the basal region of the lung and mild cardiomegaly
(Figure 4). The high-resolution computed tomographyFigure 1: Photograph of the patient showing pinched nose and
forte ring appearance of mouth.sections closer to the lung bases showed evidence of inter-
stitial lung disease (predominantly subpleural in location)
with septal thickening, bronchiectasis and fibrotic changes
(Figure 5). Her sputum was negative for AFB. An abdominal
ultrasound showed mild hepatomegaly, minimal ascites and
renal parenchymal changes. A barium swallow
examination showed moderate dilatation of 1/3 of the
oesophagus with a poor progression of peristalsis
(Figure 6). A renal Doppler showed that the main renal
artery and segmental renal arteries were a normal coloured
filling and exhibited a normal spectral wave pattern. HerFigure 4: Chest X-ray shows that interstitial lung disease shows
linear and reticular pattern, superimposed upon the ground-glass
attenuation in the basal region of lung and mild cardiomegaly.
Figure 5: A. HRCT finding of interlobular septal thickening and ground-glass attenuation was atypical, B. Paraseptal emphysematous
changes in the bilateral lower lobes, C. Reticular and linear septal thicking with collapse of bilateral upper lobes e fibrotic changes, D.
Bronchietatic changes in the posterior segments of right upper lobe.
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erythrocyte sedimentation rate was 35 mmHg.Table 1: Classification of Scleroderma at presentation.
Presenting feature Scleroderma classification
Limited
Raynauid’s phenomenon Long duration
Skin involvement Distal limbs & face
Tendon friction rubs Absent
Nail fold capillaries Dilatation
Auto antigen Commonly Centromere
Calcinosis cutis Frequent, prominent
Renal crisis Very rare
Pulmonary fibrosis Occasional, moderate
Pulmonary arterial hypertension Frequent, late, may be isolate
Figure 6: Barium swallow examination showing moderate dilata-
tion of lower 1/3rd oesophagus and throat segment stricture just
below it is noted.Radiographs of hands showed bony erosion of the ter-
minal phalanges (Figure 7). Rheumatoid factor was positive,Diffuse
Short duration
Proximal limbs & trunk
May be present
Dilatation & loss
Commonly Topoisomerase I
May occur, mild
Occurs in 15%; early
Frequent, early and Severe
d May occur, often in association with pulmonary fibrosis
Figure 7: Acro-osteolysis involving terminal phalanges of hand.
Table 2: Diagnosis of diffused cutaneous scleroderma and rheumatoid arthritis.
S. No Test Results Reference range
1 Anti-centromere antibodies (ACA) 1.26 <3.00 U/mL
2 Anti-Nuclear Antibody (ANA) 124.00 20.00 units
3 Antibodies to Topoisomerase 1 (Sc1-70) > 100.00 <3.00 U/mL
4 Hemoglobin 8 12e15 gm/dl
5 Rheumatoid Factor 80 >60 IU/mL e Strongly positive
6 Cyclic Citrullinated Peptide Antibody (CCP) 72 >60 EU/mL e Strongly positive
7 2D ECHO Cardiogram Report Pulmonary Artery Hypertension
Figure 8: A. (100) showing collagen in the dermis, B. (400) Thick collagen in the dermis. (Note: lack of skin adnexae).
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antibodies (Table 2) suggested arthritis.
A sample punch biopsy of the skin over the thigh
exhibited a normal epidermis but revealed prominent thick-
ening with space between large collagen bundles in the deep
dermis (Figure 8). This biopsy is indicative of scleroderma.
We evaluated the following autoantibodies in this patient
using an ELISA method: Anti-centromere antibodies were
negative (1.26 U/mL), and Antinuclear antibodies (124.00
units) and Anti-topoisomerase-1 antibodies (>100.00 U/mL)
were positive.Patient’s treatment and medication history
She was admitted to the RIMSGHmedical ward. She was
resuscitated and managed with 625 mg BD Tab. of
Amoxicillin þ Clavulanic acid, 4 mg HS Tablet Chlorphen-
iramine maleate, 40 mg OD, Tab. Prednisolone, 0.5 mg OD,
Tab. Colchicine, 40 mg OD and Tab. Pantoprazole and
50 mg OD Sildenafil. Following this therapeutic regimen, her
condition improved with stable vital signs. She had repeated
admissions due to cardiopulmonary complications of sys-
temic sclerosis.
Later, she was discharged from the hospital with a 5 mg
tapering dose of Prednisolone. She was followed by the
dermatology and general medicine departments of the hos-
pital. They periodically gave the patient medications.Discussion
The overlap between dcSSc and RA is relatively un-
common. To date, only a few cases of dcSSc-RA overlap
have been reported.2e4 Francesca Ingegnoli et al. reportedthat RF positivity was observed in 9 of 31 dcSSc.
Alexandra Balbir-Gurman MD and Yolanda Braun-
Moscovici reported 2 out of 10 cases of dcSSc also had
RA. Patients who develop the typical clinical features of SSc
may present with predominantly articular symptoms and
signs. This may lead to an early provisional diagnosis of
rheumatoid arthritis and specific treatment for this condi-
tion.5 In the present case, we observed and diagnosed the
patient with dcSSc-RA overlap, along with PAH, PF,
ILD and anaemia.
Scleroderma is a generalized connective tissue disease
involving sclerotic changes in the skin and many other organ
systems. The condition encompasses a spectrum of disorders
that range from localized forms, such as morphea with
limited cutaneous involvement (which may involve the in-
ternal organs after long periods), to diffuse cutaneous disease
invariably accompanied by early internal organ involvement
(Table 1).6
The preliminary criteria for the classification of SSc were
developed by the American Rheumatism Association (now
called the American College of Rheumatology) to establish
uniformity in clinical studies. The classification criteria are
not synonymous with the diagnostic criteria. However, they
will almost always mirror the criteria used for a diagnosis.
Based on The American College of Rheumatology/European
League against Rheumatism criteria for the classification of
SSc the score in our case was 15 (the maximum score is 19).
This clearly indicates that the patient had definite SSc (total
score >9).1 In our case, she had limited cutaneous
scleroderma since 2 yrs but was diagnosed with dcSSc by
confirmed positive ANA and Anti-topoisomerase-1
antibodies.
The diagnosis of RA primarily dependent on the clinical
manifestations of the disease. Although rheumatoid factor is
Scleroderma overlap syndrome 81detected in 60e80% of RA patients, the specificity of
elevated RF is inadequate (48e92%) because RF is also
detected in multiple non-RA rheumatic diseases, infectious
diseases and healthy individuals, particularly the elderly.6 In
the present case, the patient was young and did not have any
infectious diseases. A major clinical feature of SSc was
deforming, erosive polyarthritis accompanied by positive
tests for rheumatoid factor in our case. The joint
symptoms, seropositivity, presence of CCP antibodies, as
well as X-ray evidence of erosions in the joints, indicated
an aggressive form of RA. Based on a 2010 Rheumatoid
Arthritis Classification Criteria, the score in our case was 7
(RA positive >6). This clearly indicates that the patient
had rheumatoid arthritis.7
Two or more systemic autoimmune diseases may develop
in some patients in which each component fulfils the diag-
nostic criteria of the American College of Rheumatology.
Thus, in some cases of SSc, the disease may overlap with
other organ-specific or systemic autoimmune diseases, such
as RA, polymyositis, systemic lupus erythematosus and
others.8 Patients with SSc often exhibit additional clinical
features characteristic of RA, which defines the clinical
condition of SSc-RA overlap syndrome.6 In our case, the
patient had DcSSc-RA overlap syndrome.
Scleroderma is associated with a range of organ compli-
cations, including pulmonary fibrosis and pulmonary arterial
hypertension, renal disease and cardiac manifestations.9 The
association between scleroderma and pulmonary
hypertension is well established. It may be caused by pre-
capillary microvascular narrowing resulting in PAH or pul-
monary parenchymal disease, veno-occlusive disease, post-
capillary pulmonary venous hypertension from left heart
dysfunction or combinations of these abnormalities.10 In a
Royal Free Hospital cohort (London, UK), the frequency
of PAH in SSc and dcSSc and the limited cutaneous
subgroup began to increase from 2 yrs after diagnosis to
5% and 6%, respectively, after 5 yrs and 13% and 15%,
respectively, after 10 yrs (unpublished data).9 In our case,
in addition to presenting with PAH 2 yrs after diagnosis,
she also was diagnosed with pulmonary fibrosis, interstitial
lung disease and anaemia.
Conclusion
Overlap between dcSSc and RA is rare. ILD and PAH are
leading for causes of mortality. In previous studies, few cases
of dcSSc-RA have been noted. However, we found a rare
case of the combination dcSSc-RA with PF, ILD, PAH and
anaemia. This case confirms the clinical examination from
our case. Early diagnosis and management of ILD and PAH
is critical in reducing mortality in patients with SSc.Conflict of interest
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